CFCM Academy / Curriculum edition

Understand the signal.
Strengthen the interpretation.

A structured learning framework for clinical flow cytometry, from instrument physics and laboratory quality to disease-specific analysis.

Start a released lessonExplore the curriculum

Latest released learning

Lessons, cases and resources appear only after their stated editorial checks are complete. Independent scientific review is identified separately when it has actually occurred.

Lesson

Use time to investigate an acquisition anomaly

Investigate a transient event-rate change without automatically deleting inconvenient events or mistaking event order for measured time.

Open learning item →

Lesson

Titration and detector setup: change one question at a time

Plan an interpretable antibody titration without confusing reagent amount, cell number, detector settings and the performance of the full panel.

Open learning item →

Lesson

A brighter plot is not necessarily a better measurement

Use a simple measurement model to distinguish collected signal, electronic scaling and display choices. Learn why larger numbers alone do not prove better resolution.

Open learning item →

Lesson

Green beads, uncertain assay: reading QC in context

Use a synthetic change investigation to understand the boundary between an instrument QC pass and evidence that the complete assay remains fit for use.

Open learning item →

Lesson

Compensation, spreading and FMO: three different questions

Distinguish correction of fluorescence spillover from the uncertainty that remains, then use an FMO control without overclaiming what it proves.

Open learning item →

Lesson

Rare events: a count, a denominator and a defensible claim

Calculate a rare-event fraction and its idealised counting uncertainty without confusing either with validated detection, quantification or a clinical MRD conclusion.

Open learning item →

Lesson

A perfect correlation can still fail a method comparison

Use a deliberately simple comparison to distinguish correlation, bias and fitness for an intended use. Includes a worked example and a review checklist.

Open learning item →

Explore all 95 topics

Find a topic by keyword, module or disease and open its curriculum outline.

Search the curriculum

The curriculum is open to explore

Explore module outlines and learning pathways, then work through the first seven editorially approved lessons below. Each lesson includes a worked example, questions and source references. More lessons and cases are in development.

Our publishing sequence is simple: learn → verify → synthesise → publish. Each teaching item needs traceable sources and accountable editorial review before release. Independent scientific review will be identified only where it has actually occurred.

Six practical learning modules

A minimum educational layer around released guides, clinical reasoning and primary evidence. Use a module to decide what to study next; the full curriculum remains available below.

CFCM Academy / Guided learning

Fundamentals

What is this?

A measurement-based approach to interpreting light scatter and fluorescence. Start with what was acquired, the controls and the biological question before naming a population.

Why does it matter clinically?

A reproducible label requires reproducible measurement. A false rare population can arise from sample quality or acquisition rather than disease.

How is it done?

Review acquisition stability, singlets, viability where measured and internal comparators. Back-gate a proposed population across independent views. Use Shapiro for the technical framework and the practical guide for worked reasoning.

What commonly goes wrong?

Treating scatter as a diagnosis, excluding unusual events too early, or confusing compensating a mean spillover with removing spreading.

What should you look at next?

CFCM Academy / Guided learning

Panel Design

What is this?

Translate a clinical question into identity, discriminating markers, internal controls and a preparation that preserves the required signals.

Why does it matter clinically?

Adding markers cannot compensate for a missing lineage question or an unreadable weak discriminator.

How is it done?

Define the differential, select informative combinations, allocate fluorochromes with spreading in mind, titrate and assess the complete stained sample. Use the poster marker briefs as design inputs requiring local verification.

What commonly goes wrong?

Copying a tube across instruments, assuming every extra colour improves sensitivity, or extending a published validation to a therapy group it excluded.

What should you look at next?

CFCM Academy / Guided learning

Troubleshooting

What is this?

A diagnostic sequence for investigating a measurement problem while keeping competing explanations visible.

Why does it matter clinically?

An apparent abnormal phenotype can be caused by autofluorescence, Fc binding, poor viability, spreading or an unstable acquisition.

How is it done?

State the observation, compare unstained and single-stained controls where appropriate, distinguish displacement from broadening, test a specific hypothesis and verify the correction.

What commonly goes wrong?

Increasing antibody without titration, redrawing gates to hide a problem, or treating an isotype control as a universal solution.

What should you look at next?

CFCM Academy / Guided learning

Haematological Malignancies

What is this?

Disease-centred interpretation connecting phenotype with morphology, tissue context and relevant genetic evidence.

Why does it matter clinically?

The same surface pattern can support several diagnoses. A characteristic result in one compartment may conflict with a decisive finding elsewhere.

How is it done?

Identify the abnormal compartment, establish relevant lineage or clonality, construct the differential and resolve discordance. Study the CLL exercise, published lymphoma case, AML follow-up and plasma-cell illustration.

What commonly goes wrong?

Assigning a disease from one marker, a score or a narrow gate; treating a diagnostic panel as a validated MRD method.

What should you look at next?

CFCM Academy / Guided learning

Measurable Residual Disease

What is this?

A disease- and assay-specific assessment separating cell identity, detection and quantification at low abundance.

Why does it matter clinically?

A credible detected population may still be below reliable quantification. A negative specimen may not support the requested sensitivity.

How is it done?

Use the validated disease-specific strategy, assess specimen adequacy and informative events, corroborate abnormal identity and apply the actual detection and quantification limits.

What commonly goes wrong?

Transferring a published 20 / 50-event example to another method; reporting a precise percentage at or below the adopted quantification boundary; overlooking treatment interference.

What should you look at next?

CFCM Academy / Guided learning

Validation & Verification

What is this?

Document whether the complete method performs adequately for its intended clinical use, and whether an adopted method works in the local setting.

Why does it matter clinically?

An apparently clean plot does not establish sensitivity, quantitative precision, specificity or transferability.

How is it done?

Define intended use and acceptance criteria first. Assess controls, background, low-level precision, recovery, stability and relevant interferences. Evaluate the impact of changes to clones, preparation, panel or instrument.

What commonly goes wrong?

Treating a literature claim as local validation, using only abundant positives, or ignoring specimen limitations when stating the achieved sensitivity.

What should you look at next?

Evidence and scope

These modules organise existing CFCM material rather than duplicate full protocols. Primary sources and figure rights are stated in each guide, case and poster. No accreditation, validated universal panel or independent clinical review is implied.

Shapiro · Practical Flow Cytometry · 4th edition · DOI 10.1002/0471722731
Wood et al. · ICSH / ICCS assay performance criteria · DOI 10.1002/cyto.b.21108

Seven modules. One connected practice.

Start with the foundations or enter through a practical question. MRD is studied within each relevant disease pathway.

Module 01

Understanding the Physics of Flow Cytometry

Explore the instrument from sample stream to measured signal, with a learning sequence covering light, fluorescence and measurement quality.

Explore the curriculum →
Module 02

Cytometry Laboratory GMP & Quality

Follow the laboratory workflow through quality control, documentation and traceability. Topics distinguish general quality practice from requirements that depend on the laboratory's intended activities.

Explore the curriculum →
Module 03

Panel Design Insights

Build a structured approach to selecting markers and fluorochromes, then review controls and the evidence needed to assess a panel.

Explore the curriculum →
Module 04

Cytometer & Panel Setup

Connect instrument setup with panel optimisation and long-term monitoring. The curriculum separates transferable principles from instrument-specific instructions.

Explore the curriculum →
Module 05

Troubleshooting & Problem Solving

Work through problems by identifying the affected stage, checking evidence and documenting the investigation before changing a workflow.

Explore the curriculum →
Module 06

Validation & Verification

Organise a study around intended use, performance claims and the questions that its data must answer. The topics connect study design, analysis and reporting.

Explore the curriculum →
Module 07

Data Analysis of Haematological Malignancies

Learn through disease-centred pathways that connect diagnostic interpretation, follow-up and case discussion. MRD is studied within the relevant disease pathway.

Explore the curriculum →

Within data analysis

Find your disease pathway

Diagnostic interpretation, follow-up and MRD are organised in their clinical context.

Disease pathway

B-cell Acute Lymphoblastic Leukaemia (B-ALL)

A disease-centred learning pathway for B-cell Acute Lymphoblastic Leukaemia (B-ALL). Explore diagnostic interpretation, follow-up, reporting and case discussion within the same clinical context.

Explore the curriculum →
Disease pathway

T-cell Acute Lymphoblastic Leukaemia (T-ALL)

A disease-centred learning pathway for T-cell Acute Lymphoblastic Leukaemia (T-ALL). Explore diagnostic interpretation, follow-up, reporting and case discussion within the same clinical context.

Explore the curriculum →
Disease pathway

Acute Myeloid Leukaemia (AML)

A disease-centred learning pathway for Acute Myeloid Leukaemia (AML). Explore diagnostic interpretation, follow-up, reporting and case discussion within the same clinical context.

Explore the curriculum →
Disease pathway

Chronic Lymphocytic Leukaemia (CLL)

A disease-centred learning pathway for Chronic Lymphocytic Leukaemia (CLL). Explore diagnostic interpretation, follow-up, reporting and case discussion within the same clinical context.

Explore the curriculum →
Disease pathway

B-cell lymphoproliferative disorders (B-LPD)

A disease-centred learning pathway for B-cell lymphoproliferative disorders (B-LPD). Explore diagnostic interpretation, follow-up, reporting and case discussion within the same clinical context.

Explore the curriculum →
Disease pathway

Plasma cell neoplasms

A disease-centred learning pathway for Plasma cell neoplasms. Explore diagnostic interpretation, follow-up, reporting and case discussion within the same clinical context.

Explore the curriculum →
Disease pathway

Myelodysplastic neoplasms / MDS

A disease-centred learning pathway for Myelodysplastic neoplasms / MDS. Explore diagnostic interpretation, follow-up, reporting and case discussion within the same clinical context.

Explore the curriculum →

Choose a learning path

Suggested learning sequences connect the curriculum. The first seven lessons are available below; progress tracking is not active.

Cases & challenges

Start with the clinical question, then compare the observations, differential diagnoses and limits of the evidence.

Five clinical reasoning explanations are available in Clinical Cases, using published material or explicitly labelled educational exercises.

Read existing Clinical Notes →

Learning levels

Foundation → Intermediate

Build the concepts, then connect them to practical laboratory decisions.

Advanced → Expert case

Examine complex interpretation, validation decisions and uncertainty.

Search the curriculum or choose one of the released lessons. Lesson-level filters and progress tracking are not available.

Keep learning across CFCM

CFCM Academy · Independent education in clinical flow cytometry.

Educational material supports professional learning. It does not replace local procedures, manufacturer instructions or case-specific clinical judgement. No accreditation or certification is implied.

Editorial independence and author information